Lebenslauf von christoph berger

Christoph Berger, Publications
Original Papers:
1a. Berger Ch, Holzach P, Matter P. Die Skidaumenverletzung beim Kind. Helv Chir Acta 1993;60:615-

1b. Berger Ch, Holzach P, Matter P. Die Skidaumenverletzung beim Kind. Z Unfallchir
Versicherungsmed 1993 Suppl 1:222-231.
2. Berger C, Uehlinger J, Ghelfi D, Blau N, Fanconi S. Comparison of C-reactive protein and white blood cell count with differential in neonates at risk for septicemia. Eur J Pediatr 1995;154:138-144.
3. Berger C, Albisetti M, Fanconi S, Rudin CH, Cheseaux J.J, Kind C, Nadal D. Pneumocystis carinii Pneumonie bei Säuglingen mit vertikaler HIV Infektion in der Schweiz. Schweiz Med Wochenschr
4. Berger C, Pfyffer G, Nadal D. Treatment of nontuberculous mycobacterial lymphadenitis with clarithromycin plus rifabutin. J Pediatr 1996;128:383-386.
5. Berger C, Braegger CP, Albisetti M, Landau K, Nadal D. Cerebral tuberculosis presenting as complex febrile convulsions. Neuropediatrics 1996;27:161-163.
6. Knecht H, McQuain C, Martin J, Rothenberger S, Drexler HG, Berger C, Bachmann E, Kittler ELW, Odermatt BF, Quesenberry PJ. Expression of the LMP1 oncoprotein in the EBV-negative Hodgkin's
disease cell line L-428 is associated with Reed-Sternberg cell morphology. Oncogene 1996;13:947-
7. Larcher C, McQuain C, Berger C, Mitterer M, Quesenberry PJ, Huemer H, Knecht H. Epstein-Barr virus associated persistent polyclonal B-cell lymphocytosis with a distinct 69-base pair deletion in the
LMP1 oncogene. Ann Hematol 1997;74:23-28.
8. Berger C, McQuain C, Sullivan JL, Nadal D, Quesenberry PJ, Knecht H. The 30 base pair deletion variant of Epstein-Barr virus-encoded latent membrane protein-1 prevails in acute infectious
mononucleosis. J Infect Dis 1997;176:1370-1373.
9. Rothenberger S, Bachmann E, Berger C, McQuain C, Odermatt BF, Knecht H. Natural 30 base pair and 69 base pair deletion variants of the LMP1 oncogene do stimulate NF-kB- mediated
transcription. Oncogene 1997;14: 2123-2126.
10. Kershaw G, Berger C, McQuain C, Al-Homsi AS, Pihan G, Quesenberry PJ, Woda B, Knecht H. Selective outgrowth of a posttransplant B-immunoblastic lymphoma expressing a LMP1 deletion
variant. Transplantation 1997;64:1079-1081.
11. Al-Homsi AS, Berger C, van Baarle D, Kersten MJ, Klein MR, Dunn B, McQuain C, van Oers R, Knecht H. Molecular analysis of critical sequences within the EBNA2 type 1 gene from Epstein-Barr
virus (EBV) isolates from patients with infectious mononucleosis, tonsillar hyperplasia, and HIV
infection. Int J Mol Med 1998;1:983-987.
12. Berger C, van Baarle D, Kersten MJ, Klein MR, Al-Homsi AS, Dunn B, McQuain C, van Oers R, Knecht H. Carboxy-terminal variants of Epstein-Barrr Virus-encoded latent membrane protein 1
during long-term HIV infection: reliable markers for individual strain identification. J Infect Dis
13. Berger C, Rothenberger S, Bachmann E, McQuain C, Nadal D, Knecht H. Sequence Polymorphisms between latent membrane proteins LMP1 and LMP2A do not correlate in EBV-associated reactive
and malignant lymphoproliferations. Int J Cancer 1999;81:371-375.
14. Knecht H, Berger C, McQuain C, Rothenberger S, Bachmann E, Martin J, Esslinger C, Drexler HG, Cai YC, Quesenberry PJ, Odermatt BF. Latent membrane protein 1 associated signaling pathways
are important in tumor cells of Epstein-Barr virus negative Hodgkin’s disease. Oncogene
Christoph Berger, Publications, October 04, 2013, page 2 of 8 15. Panow C, Berger C, Willi U, Valavanis A, Martin E. MRI and CT of a haemangioma of the mandible in Kasabach-Merritt syndrome. Neuroradiology 2000;42:215-217.
16. Nadal D, Bossart W, Zucol F, Steiner F, Berger C, Lips U, Altwegg M. Community-acquired pneumonia in children due to Mycoplasma pneumoniae: diagnostic performance of a seminested
16S rDNA-PCR. Diagn Microbiol Infect Dis 2001;39:15-19.
17. Schäfer HJ, Berger C, Aepinus C, Hebart H, Beck R, Kaiserling E, Kanz L, Einsele H, Knecht H. Molecular pathogenesis of Epstein-Barr virus-associated post-transplant lymphomas: new insights
through latent membrane protein 1 fingerprinting. Transplantation 2001;72:492-496.
18. Berger C, Day P, Meier G, Zingg W, Bossart W, Nadal D. Dynamics of Epstein-Barr virus (EBV) DNA levels in serum during EBV-associated disease. J Med Virol 2001;64:505-512.
19. Berger C, Altwegg M, Meyer A, Nadal D. Broad-range polymerase chain reaction for diagnosis of rat-bite fever caused by Streptobacillus moniliformis. Pediatr Infect Dis J 2001;20:1181-1182.
20. Laube GF, Superti-Furga A, Losa M, Büttiker V, Berger C, Neuhaus TJ. Hyperammonaemic encephalopathy in a 13-year-old boy. Eur J Pediatr 2002;161:163-164.
21. Manz MG, Berger C, Horny HP, Beck R, Brugger W, Viebahn R, Kanz L, Knecht H. Sustained remission of an extensive monoclonal, Epstein-Barr virus-associated diffuse large B cell lymphoma
in a kidney-pancreas transplant recipient. Transplantation 2002;73:995-997.
22. Nadal D, Blasius M, Niggli FK, Meier G, Berger C. Epstein-Barr virus (EBV) DNA levels in palatine tonsils and autologous serum from EBV carriers. J Med Virol 2002;67:54-58.
23. Laube GF, Berger C, Goetschel P, Leumann E, Neuhaus TJ. Immunization in children with chronic renal failure. Pediatr Nephrol 2002;17:638-642.
24. Fischer JE, Steiner F, Zucol F, Berger C, Martignon L, Bossart W, Altwegg M, Nadal D. Use of simple heuristics to target macrolide prescription in children with community-acquired pneumonia.
Arch Pediatr Adolesc Med 2002;156:1005-1008.
25. Greiner O, Berger C, Day PJR, Meier G, Tang CM, Nadal D. Rates of detection of Neisseria meningitidis in tonsils differ in relation to local incidence of invasive disease. J Clin Microbiol
26. Erickson KD, Berger C, Coffin WF, Schiff E, Walling DM, Martin JM. Unexpected absence of the Epstein-Barr virus (EBV) lyLMP-1 open reading frame in tumor virus isolates: Lack of correlation
between Met129 status and EBV strain identity. J Virol 2003;77:4415-4422.

27. Zingg W, Kellenberger C, Frey B, Grimm F, Berger C. A 7-year-old girl with dyspnea and rash. Clin
Infect Dis 2003;37:73-74 and 129-130.
28. Gautschi O, Berger C, Gubler J, Laube I. Acute respiratory failure and cerebral hemorrhage due to primary Epstein-Barr virus infection. Respiration 2003;70:419-422.
29. Bonanomi A, Kojic D, Giger B, Rickenbach Z, Jean-Richard-Dit-Bressel L, Berger C, Niggli FK, Nadal D. Quantitative cytokine gene expression in human tonsils at excision and during histoculture
assessed by standardized and calibrated real-time PCR and novel data processing. J Immunol
30. Battegay M, Berger C, Rochlitz C, Hurwitz N, Hirsch HH, De Geyter C, Haque T, Nadal D. Epstein- Barr virus load correlating with clinical manifestation and treatment response in a patient with
angioimmunoblasticT-cell lymphoma. Antiviral Therapy 2004;9:453-459.
31. Berger C, Kindli K, Niggli F, Nadal D. Withholding initial vancomycin in febrile neutropenia despite implanted catheters. Eur J Pediatr 2004;163:422-423.
Christoph Berger, Publications, October 04, 2013, page 3 of 8 32. Giger B, Bonanomi A, Odermatt B, Ladell K, Speck RF, Kojic D, Berger C, Niggli FK, Nadal D. Human tonsillar tissue block cultures differ from autologous tonsillar cell suspension cultures in
lymphocyte subset activation and cytokine gene expression. J Immunol Methods. 2004;289:179-
33. Mühlemann K, Franzini C, Aebi C, Berger C, Nadal D, Stähelin J, Gnehm Hp, Posfay-Barbe K, Gervaix A, Heininger U, Bonhoeffer J, Eich G, Kind C, Petignat C, Scalfaro P. Prevalence of
nosocomial infection in Swiss Children’s Hospitals. Inf Control Hosp Epidemiol 2004;9:765-71.
34. Hengartner H, Berger C, Nadal D, Niggli FK, Grotzer MA. Port-a-cath infections in children with cancer. Eur J Cancer 2004;40:2452-2458.
35. Olah E, Berger C, Boltshauser E, Nadal D. Cerebral actinomycosis before adolescence. Neuropediatrics 2004;35:239-241.
36. Weibel L, Goetschel P, Meier R, Radivojevic V, Berger C. Neonatal suppurative submandibular sialadenitis. Pediatr Infect Dis J 2005;24:379-381.
37. Fleisch F, Reinhart WH, Brand B, Berger C. Epstein-Barr virus DNA in serum in a HIV-infected patient during development and treatment of non-Hodgkin’s lymphoma. Swiss Med Wkly
38. Kubat StH, Berger C, Willi UV, Huisman TAGM. Akute Pneumokokken-Meningitis 3½ Jahre nach Schädelbasisfraktur. Praxis 2005;94:879-882.
39. Iff T, Meier R, Olah E, Schneider JFL, Tibussek D, Berger C. Tick-borne meningo-encephalitis in a 6-week-old infant. Eur J Pediatr 2005;164:787-788.
40. Bernasconi M, Berger C, Sigrist JA, Bonanomi A, Sobek J, Niggli FK, Nadal D. Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an
oligonucleotide microarray.Virol J. 2006;3:43.
41. Zucol F, Ammann RA, Berger C, Aebi C, Altwegg M, Niggli FK, Nadal D. Real-time quantitative broad-range PCR assay for detection of the 16S rRNA gene followed by sequencing for species
identification. J Clin Microbiol 2006;44:2750-9.
42. Rao SP, Rechsteiner MP, Berger C, Sigrist JA, Nadal D, Bernasconi M. Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-
Barr virus infection in Burkitt’s lymphoma Akata cells. Mol Cancer 2007;6:3.
43. Weber C, Corti N, Goetschel P, Altermatt S, Huisman TAGM, Berger C: Pelvic osteomyelitis: a diagnostic challenge in children. J Pediatr Surg 2007;42:553-7.
44. Ishii H, Ogino T, Berger C, Köchli-Schmitz N, Nagato T, Takahara M, Nadal D, Harabuchi Y. Clinical usefulness of serum EBV DNA levels of BamHIW and LMP1 for nasal NK/T-cell lymphoma. J Med
45. Rechsteiner MP, Berger C, Weber M, Sigrist JA, Nadal D, Bernasconi M. Silencing of latent membrane protein 2B (LMP2B) reduces susceptibility to activation of lytic Epstein-Barr virus in
Burkitt's lymphoma Akata cells. J Gen Virol 2007;88:1454-1459.
46. Heininger U, Datta F, Gervaix A, Schaad UB, Berger C, Vaudaux B, Aebi C, Hitzler M, Kind C, Gnehm HE, Frei R, the PIGS/MRSA Study Group. Prevalence of nasal colonization with methicillin-
resistant Staphylococcus aureus (MRSA) in children. A multicenter cross-sectional study. Pediatr
Infect Dis J
47. Berger C, Hug M, Gysin C, Molinari L, Frei M, Bossart W, Nadal D. Distribution patterns of β- and γ- Herpesviruses within Waldeyer's ring organs. J Med Virol 2007;79:1147-1152.
48. Ladell K, Dorner M, Zauner L, Berger C, Zucol F, Bernasconi M, Niggli F, Speck R, Nadal D. Immune activation suppresses initiation of lytic Epstein-Barr virus infection. Cell Microbiol
Christoph Berger, Publications, October 04, 2013, page 4 of 8 49. Rechsteiner MP, Berger C, Zauner L, Sigrist JA, Weber M, Longnecker R, Bernasconi M, Nadal D. Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection.
J Virol 2008;82:1739-1747.
50. Dorner M, Zucol F, Berger C, Byland R, Melroe GT, Bernasconi M, Speck RF, Nadal D. Distinct ex vivo susceptibility of B-cell subsets to Epstein-Barr virus infection according to differentiation status
and tissue origin. J Virol 2008;82:4400-4412.
51. Neuhaus TJ*, Berger C*, Buechner K, Parvex P, Bischoff G, Goetschel P, Husarik D, Willi U, Molinari L, Rudin C, Gervaix A, Hunziker U, Stocker S, Girardin E, Nadal D. Randomised trial of oral
versus sequential intravenous/oral cephalosporins in children with pyelonephritis. Eur J Pediatr
*equal contribution
52. Weber R*, Berger C*, Balmer C, Kretschmar O, Bauersfeld U, Pretre R, Nadal D, Knirsch W. Interventions using foreign material to treat congenital heart disease in children increase the risk for
infective endocarditis. Pediatr Infect Dis J 2008;27:544-550.
*equal contribution
53. Datta F, Erb T, Heininger U, Gervaix A, Schaad UB, Berger C, Vaudaux B, Aebi C, Hitzler M, Kind C, Gnehm HP, Rei R; Pediatric Infectious Disease Group Switzerland Methicillin-Resistant
Staphylococcus aureus Study Group. A multicenter, cross-sectional study on the prevalence and risk
factors for nasal colonization with Staphylococcus aureus in patients admitted to Children's Hospitals
in Switzerland. Clin Infect Dis 2008;47:923-926.
54. Eberle P, Berger C, Junge S, Dougoud S, Valsangiacomo Büchel E, Riegel M, Schinzel A, Seger R, Güngör T. Persistent low thymic activity and non-cardiac mortality in children with chromosome
22q11.2 microdeletion and partial DiGeorge syndrome. Clin Exp Immunol 2008;155:189-198.
55. Agyeman P, Desgrandchamps D, Vaudaux B, Berger C, Diana A, Heininger U, Siegrist CA, Aebi C. Interpretation of primary care physicians' attitude regarding rotavirus immunisation using diffusion of
innovation theories. Vaccine 2009;27:4771-4775.
56. Bihl F, Berger C, Chisholm JV, Henry LM, Bertisch B, Trojan A, Nadal D, Speck RF, Flepp M, Brander C, Mueller NJ, and the Swiss HIV Cohort Study. Cellular immune responses and disease
control in acute AIDS-associated Kaposi's sarcoma. AIDS 2009;23:1918-1922.
57. Huber C, Cozzio A, Berger C, Weibel L. Picture of the Month – Quiz Case (Cutaneous Leishmaniasis by Leishmania infantum). Arch Pediatr Adolesc Med 2009;163:1061-1062.
58. Dorner M, Brandt S, Tinguely M, Zucol F, Bourquin JP, Zauner L, Berger C, Bernasconi M, Speck RF, Nadal D. Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma
cell TLR triggering enhances immunoglobulin production. Immunology 2009;128:573-579.
59. Fischer C, Meylan P, Bickle Graz M, Gudinchet F, Vaudaux B, Berger C, Roth-Kleiner M. Severe postnatally acquired cytomegalovirus infection presenting with colitis, pneumonitis and sepsis-like
syndrome in an extremely low birthweight infant. Neonatology 2010;97:339-345.
60. Schlagenhauf P, Chen LH, Wilson ME, Freedman DO, Tcheng D, Schwartz E, Pandey P, Weber R, Nadal D, Berger C, von Sonnenburg F, Keystone J, Leder K, for the GeoSentinel Surveillance
Network Clinical Infectious Diseases. Sex and gender differences in travel-associated disease. Clin
Infect Dis
61. Dorner M, Zucol F, Alessi D, Haerle SK, Bossart W, Weber M, Byland R, Bernasconi M, Berger C, Tugizov S, Speck RF, Nadal D. β1 Integrin expression increases susceptibility of memory B-cells to
Epstein-Barr virus infection. J Virol 2010;84:6667-6677.
62. Gessler P, Martin F, Suter D, Berger C. Invasive pneumococcal disease in children prior to implementation of the conjugate vaccine in the Zurich region, Switzerland. Acta Paediatr
Christoph Berger, Publications, October 04, 2013, page 5 of 8 63. Zauner L, Melroe GT, Sigrist JA, Rechsteiner MP, Dorner M, Arnold M, Berger C, Bernasconi M, Schaefer BW, Speck RF, Nadal D. TLR9 triggering in Burkitt's lymphoma cell lines suppresses the
EBV BZLF1 transcription via histone modification. Oncogene 2010;29:4588-4598.
64. Hug M, Dorner M, Zucol Fröhlich F, Gysin C, Neuhaus D, Nadal D*, Berger C*. Pediatric Epstein- Barr virus carriers with or without tonsillar enlargement may substantially contribute to spreading of
the virus. J Infect Dis 2010;202:1192-1199.
*equal contribution
65. Mégevand C, Gervaix A, Heininger U, Berger C, Aebi C, Vaudaux B, Kind C, Gnehm HP, Hitzler M, Renzi G, Schrenzel J, François P for the Paediatric Infectious Disease Group Switzerland. Molecular
epidemiology of the nasal colonization by methicillin-susceptible Staphyloccocus aureus in Swiss
children. Clin Microbiol Infect 2010;16:1414-1420.
66. Wunderli W, Meerbach A, Guengoer T, Berger C, Greiner O, Caduff R, Trkola A, Bossart W, Gerlach D, Schibler M, Cordey S, McKee TA, Van Belle S, Kaiser L, Tapparel C. Astrovirus infection in
hospitalized infants with severe combined immunodeficiency after allogeneic hematopoietic stem cell
transplantation. PLoS ONE 2011;6:e27483.
67. Hunziker T, Berger C, Staubli G, Tschopp A, Weber R, Nadal D, Hatz C, Schlagenhauf P. Profile of travel-associated illness in children, Zurich, Switzerland. J Travel Med 2012;19:158-162.
68. Bielicki J, Achermann R, Berger C. Timing of measels immunizations and effective population vaccine coverage. Pediatrics 2012;130:e600.
69. Bansal V, Altermatt S, Nadal D, Berger C. Lack of benefit of preoperative antimicrobial prophylaxis in children with acute appendicitis: a prospective cohort study. Infection 2012;40:635-641.
70. Meyer Sauteur PM, Relly C, Hug M, Wittenbrink MM, Berger C. Risk factors for invasive reptile- associated salmonellosis in children. Vector Borne Zoonotic Dis 2013;13:419-421.
71. Bernasconi M, Ueda S, Krukowski P, Bornhauser BC, Ladell K, Dorner M, Sigrist JA, Campidelli C, Aslandogmus R, Alessi D, Berger C, Pileri SA, Speck RF, Nadal D. Early gene expression changes
by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-
transplant lymphoproliferative diseases. Int J Cancer 2013;133:2341-2350.
72. Manuel O, Kralidis G, Mueller NJ, Hirsch HH, Garzoni C, van Delden C, Berger C, Boggian K, Cusini A, Koller MT, Weisser M, Pascual M, Meylan PR, and the Swiss Transplant Cohort Study. Impact of
antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid-
organ transplant recipients. Am J Transplant 2013;13:2402-2410.
73. Meyer Sauteur PM, Relly C, Hackenberg A, Stahr N, Berger C, Bloemberg GV, Jacobs E, Nadal D. Mycoplasma pneumoniae intrathecal antibody responses in Bickerstaff brainstem encephalitis.
Neuropediatrics 2013; in press
74. Ueda S, Uchiyama S, Azzi T, Gysin C, Berger C, Bernasconi M, Harabuchi Y, Zinkernagel AS, Nadal D. Oropharyngeal Group A Sreptococcal colonization disrupts latent Epstein-Barr virus infection. J
Infect Dis
2013; in press
75. Bielicki JA, Achermann R, Berger C. In touch but not up-to-date: Ambulatory visits and vaccination status in a cohort of young Swiss children. Vaccine 2013; in press

Letter to the Editor:

1. Nadal
Berger C, Aebi C, Kind C. Prophylaxis for respiratory syncytial virus bronchiolitis. Lancet

2. Berger C. Vorgehen bei Tonsillopharyngitis. Schweiz Med Forum 2003;47:1149-1150.
Christoph Berger, Publications, October 04, 2013, page 6 of 8
Collaborative Studies:

1. Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, Calandra T, Glauser MP, Täuber
MG, Pittet D and the Fungal Infection Network of Switzerland (FUNGINOS). Epidemiology of
Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991-2000. Clin Infect Dis
2. Vu NV, Baroffio A, Huber P, Layat C, Gerbase M, Nendaz M and the Pilot examination blueprint working group. Assessing clinical competence. Swiss Med Wkly 2006;136:392-399.
3. Rudin C, Wolbers M, Nadal D, Rickenbach M, Bucher HC; the Pediatric Infectious Disease Group of Switzerland (PIGS) and the Swiss Mother and Child HIV Cohort Study (MoCHiV). Long-term safety
and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children. Arch Dis
4. Steinbach WJ, Roilides E, Berman D, Hoffman JA, Groll AH, Bin-Hussain I, Palazzi DL, Castagnola E, Halasa N, Velegraki A, Dvorak CC, Charkabarti A, Sung L, Danziger-Isakov L, Lachenauer C,
Arrieta A, Knapp K, Abzug MJ, Ziebold C, Lehrnbecher T, Klingspor L, Warris A, Leckerman K,
Martling T, Walsh TJ, Benjamin DK, Zaoutis TE and the International Pediatric Fungal Network.
Results from a prospective, international epidemiologic study of invasive candidiasis in children and
neonates. Pediatr Infect Dis J 2012;31:1252-1257.
5. Versporten A, Sharland M, Bielicki J, Drapier N, Vankerckhoven V, Goossens H for the ARPEC Project Group Members. The antibiotic resistance and prescribing in European children project: A
neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide.
Pediatr Infect Dis J 2013;32:e242-e253.


1. Berger C, Brousset P, McQuain C, Knecht H. Deletion variants within the NF-kB activation domain of
the LMP1 oncogene in acquired immunodeficiency syndrome-related large cell lymphomas, in
prelymphomas and atypical lymphoproliferations. Leukemia and Lymphoma 1997;26:239-250.
Berger C, Al-Homsi AS, McQuain C, Brousset P. Epstein-Barr Virus Oncogenesis. Crit
Rev Onc/Hematol 1997;26:117-135.

3. Berger C, Michel K. Akute Otitis media: Vorschlag für ein neues Management. Paediatrica
Berger C, Rothenberger S, Odermatt BF, Brousset P. The role of Epstein-Barr virus in neoplastic transformation. Oncology 2001;60:289-302.
Berger C, Linder T. Akute Otitis media weiterhin im Gespräch. Schweiz Med Forum

6. Berger C. Infektiöse Mononukleose. Ther Umschau 2003;60:625-630.
7. Berger C, Desgrandchamps D, Diana A, Duppenthaler A, Gervaix A, Gnehm Hp, Heininger U,
Schwöbel M. Perioperative Antibiotikaprophylaxe bei Kindern. Paediatrica 2005;16:30-33.

8. Berger C. Der Schweizerische Impfplan 2008: Welche Impfungen sind empfehlenswert? Pädiatrie
9. Rechsteiner MP, Bernasconi M, Berger C, Nadal D. Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency. Trends Microbiol 2008;16:520-527.
10. Frey B, Berger C, Kind C, Vaudaux B. Triageempfehlungen für Aufnahme und Verbleib von Kindern auf der Intensivstation bei Influenza-Pandemie. Schweiz Arzteztg 2010;91:715-718.
Christoph Berger, Publications, October 04, 2013, page 7 of 8 11. Bühlmann M, Berger C, Heininger U, Vaudaux B, Widmer AF. Empfehlungen für den Impfschutz in Spitalkinderkrippen. Swiss-NOSO 2010;16:1-3.
12. Berger C. Zeckenstiche, Frühsommer-Meningo-Enzephalitis (FSME) und FSME-Impfung beim Kind. Paediatrica 2011;22;20-22.
13. Bialek R, Knuf M, Tenenbaum T, Vogel U, Zenz W, Zwiauer K, Berger C. Pädiatrische Konsensusempfehlung Impfung mit konjugiertem Meningokokken ACWY-Impfstoff. Kinder- und
2011;42:Supplement 1-7.
14. Berger C, Boggian K, Cusini A, van Delden C, Garzoni C, Hirsch HH, Khanna N, Koller M, Oriol M, Meylan P, Nadal D, Weisser M, Mueller NJ, Transplant Infectious Diseases Working Group, Swiss
Transplant Cohort Study. Relevance of cohort studies for the study of transplant infectious diseases.
Curr Opin Organ Transplant 2012;17:581-585.
15. Schlapbach LJ, Agyeman P, Posfay-Barbe K, Giannoni E, Donas A, Heininger U, Konetzny G, Leone A, Niederer-Loher A, Wagner B, Aebi C, Berger C für die Swiss Pediatric Sepsis Study. Warum
erkranken Kinder an einer bakteriellen Sepsis? Paediatrica 2012;23:20-23.
16. Berger C, Giannoni E. McDougall J, Stocker M. Empfehlungen zur Prävention und Therapie von Termin- und knapp frühgeborenen Kindern (>34 SSW) mit erhöhtem Risiko einer perinatalen
bakteriellen Infektion (early-onset Sepsis). Paediatrica 2013;24/1:11-13.
17. Berger C, Rudin C, Gobet R, Niederer A, Posfay Barbe K, Laube G, Agyeman P, Girardin E. Diagnose und Behandlung von Harnwegsinfektionen beim Kind. Empfehlungen der Schweizerischen
Arbeitsgruppe für pädiatrische Nephrologie (SAPN), der Pädiatrischen Infektiologiegruppe Schweiz
(PIGS) und der Schweizerischen Gesellschaft für Kinderurologie (SwissPU). Paeditrica
18. Berger C, Giannoni E. McDougall J, Stocker M. Recommendations for the treatment of term and late preterm infants at risk for perinatal bacterial infection. Revised Guidelines of the Swiss Society of
Neonatology and the Pediatric Infectious Disease Group of Switzerland (PIGS). Swiss Med Wkly
2013; in press

Book Chapters:

1. Berger C, Nadal D. Bakteriologische Diagnostik. In: Pädiatrische Pneumologie. Eds. Rieger C, von
der Hardt H, Sennhauser FH, Wahn U, Zach M. Springer Verlag Berlin, 1999, pp 259-266 and 2nd Edition 2004, pp 240-247. 2. Berger C. Chapters Bakteriämie und Sepsis; Typhus. In: Lehrbuch Pädiatrie. Eds. Speer CP, Gahr M. Springer Verlag Heidelberg, 2001, pp 413-416 and 423-424, 2nd Edition 2004, pp 471-475 and 481-482, 3rd Edition 2009, pp 385-390 and 393-394, and 4th Edition 2013, pp 371-375 and 379-380. 3. Nadal D, Berger C. Bakterielle Infektionen beim Kind. ComMed Verlagsagentur Basel, 2003, pp 1- 4. Weiss M, Bartmann P, Belohradsky BH, Berger C, Eber SW, Schulte-Wissermann H, Wolf H. Chapter Infektionsprophylaxe bei Asplenie. In Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und Jugendlichen. Thieme Verlag, Stuttgart, 5th Edition 2009; pp 122-125. 5. Schroten H, Adam R, Berger C, Rüggeberg J, Schaad UB, Tenenbaum T. Chapters Bakterielle Meningitis, and Hirnabszess und intrakraniales Empyem. In Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und Jugendlichen. Thieme Verlag, Stuttgart, 5th Edition 2009; pp 729-731, 6th Edition 2013, pp 727-736. 6. Barben J, Berger C, Bodmer T, Egger JM, Merlani G, Helbling P, Janssens JP, Nadal D, Nicod L, Turk A, Vukmirovic B, Zellweger JP, Zimmerli S. Handbuch Tuberkulose. Lungenliga Schweiz, Bundesamt für Gesundheit 2011; pp 1-88. Christoph Berger, Publications, October 04, 2013, page 8 of 8 7. Heininger U, Berger C, Bruns R, Knuf M, Liese JG, Zenz W, Zepp F. Chapter Schutzimpfungen. In Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und Jugendlichen. Thieme Verlag, Stuttgart, 6th Edition 2013, pp. 35-43. 8. Simon A, Berger C, Bruns R, Heininger U. Chapter Multiresistente Erreger. In Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und Jugendlichen. Thieme Verlag, Stuttgart, 6th Edition 2013, pp 66-76. 9. Borte M, Berger C, Bruns R, Höhne M. Chapter Norovirusinfektionen. In Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und Jugendlichen. Thieme Verlag, Stuttgart, 6th Edition 2013, pp 416-417. 10. Höger P, Berger C, Deleré Y, Hillemanns P. Chapter Papillomvirusinfektionen. In Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und Jugendlichen. Thieme Verlag, Stuttgart, 6th Edition 2013, pp 418-421. 11. Berger C, Forster J, Liese JG. Chapters Infektiöse Rhinitis, and akute Sinusitis. In Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und Jugendlichen. Thieme Verlag, Stuttgart, 6th Edition 2013, pp 607-612. 12. Liese JG, Berger C, Berner R, Forster J, Luckhaupt H, Scholz H. Chapters Akute Otitis media, and Mastoiditis. In Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und Jugendlichen. Thieme Verlag, Stuttgart, 6th Edition 2013, pp 612-620. 13. Nicolai T, Berger C, Heininger U. Chapter Epiglottitis. In Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und Jugendlichen. Thieme Verlag, Stuttgart, 6th Edition 2013, pp 620-624. 14. Lehrnbecher T, Berger C, Beutel K, Dornbusch H-J, Groll AH, Kontny U, Laws H-J, Simon A. Chapter Infektionen bei pädiatrisch-onkologischen Patienten. In Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) Handbuch: Infektionen bei Kindern und Jugendlichen. Thieme Verlag, Stuttgart, 6th Edition 2013, pp 705-715. 15. Berger C. Chapters Nosokomiale Infektionen der Atemwege, and Pleuropneumonie. In Pädiatrische Pneumologie. Eds. Mutius E, Gappa M, Eber E, Frey U. Springer Verlag, Berlin; 2013, in press
Masters directed by C. Berger:

1. Sticher Benjamin. Infektionsschutz- und Hygienemassnahmen in Kindertagesstätten der Stadt Zürich
– eine explorative Studie. Masterarbeit Medizinische Fakultät, Zürich 2013.

MD Thesis directed by C. Berger:
1. Bansal Zweifel Vineeta. Lack of benefit of preoperative antimicrobial prophylaxis in children with
acute appendicitis: a prospective cohort study. Med. Diss., Zürich 2012. 2. Plesko-Altermatt Nicole. Acute hematogenous osteomyelitis in children: Review of 50 cases at the University Children's Hospital Zurich. Med. Diss., Zürich 2012.

Source: http://www.eicr.uzh.ch/aboutus/people/Infektiologie/team/CB/Publist_engl_2013_10_04.pdf


estrogens. Transdermally delivered estradiol is metabolized only to a small extent by the skin and bypasses the Effects on Uterine Bleeding or Spotting INDICATIONS AND USAGE Impaired Liver Function and Past History of Cholestatic Jaundice first-pass effect seen with orally administered estrogen products. Therapeutic estradiol serum levels with lowerWith the Continuous Combined regi


Cardiovascular drugs in human mechanical nociception: digoxin, amlodipine, propranolol, pindolol and atenolol. Alfredo Del Giaccio1 and Antonio Eblen-Zajjur2. 1Servicio de Medicina Interna, Hospital Universitario “Dr. Angel Larralde”,Instituto Venezolano de los Seguros Sociales y2Departamento de Ciencias Fisiológicas, Facultad de Ciencias de la Salud,Universidad de Carabobo, Valencia,

© 2008-2018 Medical News